NIMR, partners to begin SARMAAN 2 to reduce infant mortality

The Nigerian Institute of Medical Research (NIMR) says its ongoing Safety and Antimicrobial Resistance Mass Administration of Azithromycin (SARMAAN) project is targeted at reducing infant mortality in the country.
Babatunde Salako, NIMR director-general, disclosed this at the SARMAAN engagement meeting with the Minister of State for Health and Social Welfare, Tunji Alausa.
Mr Salako said the project was in partnership with Sight Saver, Malaria Consortium, eHealth Africa, Federal Ministry of Health, African Field Epidemiology Network (AFENET), and Institute for Disease Modelling (IDM).
He explained that the first phase of SARMAAN was initiated two years ago following a recommendation from the World Health Organisation (WHO) on mass administration of Azithromycin in countries with high infant mortality rates.
He noted that the project’s first phase, SARMAAN 1, had been completed in six pilot states – Kebbi, Kano, Sokoto, Abia, Jigawa, Akwa Ibom and Sokoto.
“The SARMAAN project is directed at reducing under-5 mortality, and this came up from a study supported by some funders and monitored by WHO in countries where infant mortality was high. Mass Administration of Azithromycin was used in the countries, and it brought about a 13.8 per cent reduction, which was significant in those countries,” said Mr Salako.
The NIMR boss added that SARMAAN 1 was concluded in six pilot states that benefited from the mass Administration, where infants between one month and eleven months were given Azithromycin at six-month intervals.
SARMAAN’s principal investigating officer, Oliver Ezechi, said phase two of the project would commence in Kano in July.
Mr Ezechi, a research director at NIMR, said the project, which captured no fewer than 1.3 million children from one month to 11 months of age, used 3.6 million quantities of Azithromycin over six-month intervals.
He added that SARMAAN 2 would focus on reducing infant mortality and evaluating the safety of the mass administration of the drugs among children aged one to 59 months in the next four years.
Mr Ezechi explained that SARMAAN 1 was limited research that involved six states. The project showed that Azithromycin was safe for children and less than two per cent reported common side effects.
(NAN)
We have recently deactivated our website's comment provider in favour of other channels of distribution and commentary. We encourage you to join the conversation on our stories via our Facebook, Twitter and other social media pages.
More from Peoples Gazette

States
Independence: NBA urges Nigerians to expect better future
The NBA said that ordinary Nigerians should be deriving benefit from the subsidy removal rather than hardship.

Agriculture
FG tasks ECOWAS on leveraging financing strategies for agroecology
The federal government has urged stakeholders in the agriculture and finance sectors in the West Africa region to leverage financing strategies to enhance agroecology practices

Politics
Katsina youths pledge to deliver over 2 million votes to Atiku
“Katsina State is Atiku’s political base because it is his second home.”

Heading 4
Tinubu Interview: Diana London says $4.5 million did not hit her account from Nigeria
Ms London, a woman with a history of theft, said her visit to Nigeria was to interview Mr Tinubu for a documentary.

NationWide
ADC asks Tinubu to explain $4.5 million payment to U.S. lobbyist Diana LondonÂ
Mr Ologbondiyan described the reported payment as disturbing and wasteful.

Lagos
Man with Nigerian, Canadian passports killed in Lagos accident
Mr Adeola said the deceased’s remains had been deposited in a hospital morgue.

Heading 1
Only education can defeat terrorism, says Buratai
Mr Buratai said national development must go beyond infrastructure.

Heading 2
21 ISWAP fighters killed in Borno
The raids were conducted by the air assets of the troops between Monday and Tuesday.

Anti-Corruption
Court remands socialite over alleged N603 million NNPC job scam
Ms Tejuosho, however, pleaded not guilty to all five counts when they were read to her.





